GFAP and Alzheimer disease: Furthermore, a disconnect between DED retention and GFAP staining in an FAD mouse model has raised concerns over the specificity of the ligand [73], suggesting that at present, there is no clear evidence for an early inflammatory (astroglia) reaction in human AD [74].